As of 2026-09-11, the Intrinsic Value of Neximmune Inc (NEXI) is -74.16 USD. This NEXI valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Neximmune Inc is -74,161,600.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Neximmune Inc (NEXI) is overvalued by 74,161,600.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -74.16 - -74.16 | -74.16 | -74,161,600.00% |
| P/E | (393.35) - (417.38) | (402.70) | -402697103.6% |
| DDM - Stable | (209.30) - (1,556.93) | (883.12) | -883115207.9% |
| DDM - Multi | (617.30) - (3,575.70) | (1,053.35) | -1053352618.0% |
| Market Cap (mil) | 0.00 |
| Beta | 8,433.44 |
| Outstanding shares (mil) | 1.39 |
| Enterprise Value (mil) | -2.42 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.91% |
| Cost of Debt | 5.00% |
| WACC | 5.29% |